Device-associated pneumonia of very low birth weight infants in Polish Neonatal Intensive Care Units

Adv Med Sci. 2016 Mar;61(1):90-5. doi: 10.1016/j.advms.2015.09.002. Epub 2015 Sep 26.

Abstract

Purpose: Late-Onset Pneumonia (LO-PNEU) is still the most important complication associated with the hospitalization of infants with very low birth weight (<1501g). The purpose of this paper is to summarize the results of an ongoing surveillance program defining LO-PNEU as associated or not associated with respiratory support in the NICU and distribution of causative pathogens from the Polish Neonatology Surveillance Network (PNSN).

Materials and methods: Surveillance of infections was conducted in the years 2009-2011 at six Polish NICUs.

Results: The incidence was 3.1/1000 NICU patient days (pds). The mean gestational age and birth weight among infants with LO-PNEU were significantly lower. The VAP incidence was of 18.2/1000 NICU pds for mechanically ventilated (MV) infants, while the rates for those receiving only CPAP were as low as 7.7/1000 NICU pds. MV significantly increased the risk of PNEU, but MV or CPAP for <10 days did not increase the risk of LO-PNEU. Significantly associated with LO-PNEU was the use of central or peripheral venous catheters and total parenteral nutrition for longer periods. Microorganisms isolated in cases of LO-PNEU were Gram-positive cocci (53.5%) and Gram-negative rods, with predominating E. coli. Non fermentative bacilli were significantly more frequent in cases of VAP than in other cases.

Conclusions: Observed incidence rates associated with VAP and CPAP-PNEU, were higher than in other national surveillance systems and expressing the feasibility of lowering the risk of LO-PNEU and increasing patient safety. The incidence of pneumonia was found to be lower when using CPAP as compared to using MV.

Keywords: Device-associated pneumonia; Non fermentative bacilli; Pneumonia; Surveillance; Very low birth weight newborns.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight / physiology*
  • Intensive Care Units, Neonatal / statistics & numerical data*
  • Male
  • Pneumonia, Ventilator-Associated / blood
  • Pneumonia, Ventilator-Associated / drug therapy
  • Pneumonia, Ventilator-Associated / epidemiology*
  • Pneumonia, Ventilator-Associated / microbiology
  • Poland / epidemiology
  • Respiratory System / microbiology

Substances

  • Anti-Bacterial Agents